Juraj Slabý

705 total citations
5 papers, 95 citations indexed

About

Juraj Slabý is a scholar working on Economics and Econometrics, Management of Technology and Innovation and General Health Professions. According to data from OpenAlex, Juraj Slabý has authored 5 papers receiving a total of 95 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 2 papers in Management of Technology and Innovation and 1 paper in General Health Professions. Recurrent topics in Juraj Slabý's work include Pharmaceutical Economics and Policy (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Intellectual Property and Patents (2 papers). Juraj Slabý is often cited by papers focused on Pharmaceutical Economics and Policy (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Intellectual Property and Patents (2 papers). Juraj Slabý collaborates with scholars based in Czechia, Croatia and Poland. Juraj Slabý's co-authors include Guenka Petrova, Paweł Kawalec, Jurij Fürst, Zoltán Kaló, Jolanta Gulbinovič, Ewa Stawowczyk, Anna Bucsics, Marcin Czech, Ingrid Zechmeister‐Koss and Maria Kamusheva and has published in prestigious journals such as Frontiers in Pharmacology, Value in Health and Orphanet Journal of Rare Diseases.

In The Last Decade

Juraj Slabý

5 papers receiving 95 citations

Peers

Juraj Slabý

EE

PPCH

MTI

PHYSI

GENET

Suzanne White Junod United States

Rasha Hamra Lebanon

Jolanta Gulbinovič Lithuania

Matan C. Dabora United States

Abrar-Ahmad Zulfiqar France

Eleanor Dinnett United Kingdom

Jill Meinert United States

Claudio Lombardo Italy

Susana Herranz Spain

Amanda Yun Rui Lam Singapore

Suzanne White Junod United States

Juraj Slabý

12 ×0.3

EE

23 ×1.1

PPCH

2 ×0.2

MTI

11 ×1.1

PHYSI

5 ×0.5

GENET

Citations per year, relative to Juraj Slabý Juraj Slabý (= 1×) peers Suzanne White Junod

Countries citing papers authored by Juraj Slabý

Since Specialization

Citations

This map shows the geographic impact of Juraj Slabý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juraj Slabý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juraj Slabý more than expected).

Fields of papers citing papers by Juraj Slabý

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juraj Slabý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juraj Slabý. The network helps show where Juraj Slabý may publish in the future.

Co-authorship network of co-authors of Juraj Slabý

This figure shows the co-authorship network connecting the top 25 collaborators of Juraj Slabý. A scholar is included among the top collaborators of Juraj Slabý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juraj Slabý. Juraj Slabý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Krulichová, Iva Selke, Gisbert Selke, Marion Bennie, et al.. (2022). Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study. Pharmacoepidemiology and Drug Safety. 31(10). 1046–1055. 26 indexed citations

2.

Malinowski, Krzysztof Piotr, Paweł Kawalec, Christoph Sowada, et al.. (2020). Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe. Orphanet Journal of Rare Diseases. 15(1). 277–277. 13 indexed citations

3.

Malinowski, Krzysztof Piotr, Paweł Kawalec, Marcin Czech, et al.. (2019). Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries. Frontiers in Pharmacology. 10. 24 indexed citations

4.

Zelei, Tamás, Francis Arickx, Anna Bucsics, et al.. (2018). The European challenges of funding orphan medicinal products. Orphanet Journal of Rare Diseases. 13(1). 184–184. 31 indexed citations

5.

Bochenek, Tomasz, Anna Bucsics, Elfi De Weerdt, et al.. (2016). Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries. Value in Health. 19(7). A445–A445. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact